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Objective: To analyze the complications of percutaneous transthoracic needle biopsy using CT-based imaging modalities for 
needle guidance in comparison with fluoroscopy in a large retrospective cohort. 
Materials and Methods: This study was approved by multiple Institutional Review Boards and the requirement for informed 
consent was waived. We retrospectively included 10568 biopsies from eight referral hospitals from 2010 through 2014. In 
univariate and multivariate logistic analyses, 3 CT-based guidance modalities (CT, CT fluoroscopy, and cone-beam CT) were 
compared with fluoroscopy in terms of the risk of pneumothorax, pneumothorax requiring chest tube insertion, and hemoptysis, 
with adjustment for other risk factors.
Results: Pneumothorax occurred in 2298 of the 10568 biopsies (21.7%). Tube insertion was required after 316 biopsies 
(3.0%), and hemoptysis occurred in 550 cases (5.2%). In the multivariate analysis, pneumothorax was more frequently 
detected with CT {odds ratio (OR), 2.752 (95% confidence interval [CI], 2.325–3.258), p < 0.001}, CT fluoroscopy (OR, 1.440 
[95% CI, 1.176–1.762], p < 0.001), and cone-beam CT (OR, 2.906 [95% CI, 2.235–3.779], p < 0.001), but no significant 
relationship was found for pneumothorax requiring chest tube insertion (p = 0.497, p = 0.222, and p = 0.216, respectively). 
The incidence of hemoptysis was significantly lower under CT (OR, 0.348 [95% CI, 0.247–0.491], p < 0.001), CT fluoroscopy 
(OR, 0.594 [95% CI, 0.419–0.843], p = 0.004), and cone-beam CT (OR, 0.479 [95% CI, 0.317–0.724], p < 0.001) guidance. 
Conclusion: Hemoptysis occurred less frequently with CT-based guidance modalities in comparison with fluoroscopy. 
Although pneumothorax requiring chest tube insertion showed a similar incidence, pneumothorax was more frequently 
detected using CT-based guidance modalities.
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INTRODUCTION
Image-guided percutaneous transthoracic needle biopsy 
(PTNB) plays a key role in the pathologic evaluation of 
pulmonary parenchymal lesions (1, 2). Fluoroscopy was the 
conventional guidance modality of choice for PTNB, but 
with the development of CT technologies, CT-based guidance 
modalities such as CT, CT fluoroscopy, and cone-beam CT 
have been introduced for PTNB. These CT-based modalities 
allow more accurate needle placement than that achieved 
with fluoroscopy, and the diagnostic accuracy of PTNB 
conducted using these modalities is as high as 97% (3, 4).
Although PTNB has been recognized as a safe and 
relatively noninvasive diagnostic procedure, it is inevitably 
accompanied by a risk of procedure-related complications 
(5). In a recent meta-analysis of the complication rates of 
CT-guided PTNB (6), minor complications of core biopsy 
and fine-needle aspiration (FNA) were commonly observed 
with rates of 38.8% (95% confidence interval [CI], 34.3–
43.5%) and 24.0% (95% CI, 18.2–30.8%), whereas major 
complications were infrequent, with rates of 5.7% (95% CI, 
4.4–7.4%) and 4.4% (95% CI, 2.7–7.0%), respectively. In 
comparison with fluoroscopic guidance, CT-based guidance 
modalities may prove beneficial for avoiding procedure-
related complications by facilitating precise planning 
and secure placement of the biopsy needle (4). However, 
the impact of these CT-based imaging modalities on the 
complications of PTNB has not yet been critically evaluated 
in comparison with conventional fluoroscopic guidance, 
and there is limited comparison of the complication rates 
in small numbers of patients across CT-based guidance 
modalities (7-9). 
Thus, we sought to analyze the complications of PTNB 
performed using CT-based imaging modalities for needle 
guidance in comparison with that performed using 
fluoroscopy in a large retrospective cohort. 
 
MATeRIAls AND MeThODs
study Design and Population
The Korean Registry of Percutaneous Needle Lung Biopsy 
group was organized to perform this multi-institutional 
cohort study. We retrospectively collected information 
about consecutive patients who underwent PTNBs at 
eight participating hospitals from January 2010 through 
December 2014. The participating institutions consisted 
H hospital: 1258 biopsies in 1219 patients (mean age, 64.7 years; M:F = 770:449)
G hospital: 913 biopsies in 851 patients (mean age, 65.4 years; M:F = 527:324)
F hospital: 3558 biopsies in 3315 patients (mean age, 63.6 years; M:F = 1992:1323)
E hospital: 502 biopsies in 460 patients (mean age, 71.3 years; M:F = 304:156)
D hospital: 1587 biopsies in 1488 patients (mean age, 64.7 years; M:F = 911:577)
C hospital: 324 biopsies in 313 patients (mean age, 63.5 years; M:F = 199:114)
B hospital: 2224 biopsies in 1981 patients (mean age, 64.7 years; M:F = 1250:731)
A hospital: 202 biopsies in 196 patients (mean age, 65.4 years; M:F = 132:64)
10568 biopsies in 9823 patients in study population
10579 biopsies in 9834 consecutive patients undergoing percutaneous
transthoracic biopsy in 9 participating hospitals from 2010 through 2014
11 biopsies in 11 patients below 20 years of age
Fig. 1. Flow diagram of patient inclusion. F = female, M = male
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of six tertiary and two secondary referral hospitals in the 
metropolitan area of Seoul, with 555–2320 hospital beds. 
We included patients aged at least 20 years who had 
undergone PTNB and had available preprocedural chest CT 
images. During the study period, a total of 10568 biopsies 
in 9823 patients (mean age, 64.7 ± 11.8 years; male-to-
female ratio, 6085:3738) were included in this study (Fig. 1). 
PTNBs were performed twice in 639 patients and 3 times or 
more in 44 patients: 502 biopsies for the same lesion within 
one year of an initial biopsy; 151 biopsies for the same 
lesion one year after the initial biopsy; and 85 biopsies 
for a different lesion. Repeat biopsies for the same lesion 
and biopsies for different lesions were considered to be 
separate PTNBs. The number of patients included from the 
participating institutions ranged from 196 to 3315 patients 
(median, 1035 patients). This study was approved by the 
Institutional Review Board of each participating hospital, 
and the requirement for informed consent from patients was 
waived.
Biopsy Procedures 
In each participating hospital, PTNB was performed 
primarily by a dedicated thoracic radiologist who had 
performed at least 100 PTNBs before 2010, but training 
residents or fellows were sometimes involved in a particular 
portion of the PTNB procedure under the supervision of the 
thoracic radiologist. The participating institutions used 
different principal guidance modalities with a coaxial or 
non-coaxial needle (Table 1). 
Data Collection
Data collection commenced in April 2016 and the 
data were locked as of August 2017. A trained nurse or 
designated investigator at the participating institutions 
collected information regarding patient and lesion 
characteristics using a standardized form, along with 
detailed information about the biopsy procedure. The 
patient characteristics included age, sex, smoking 
history, and emphysema, which was visually assessed on 
preprocedural CT images by a designated investigator. The 
lesion characteristics encompassed the long-axis diameter 
of the lesion, internal composition (solid versus subsolid), 
lobar location, and the distance from the pleura to the 
target lesion. Information about the biopsy procedure 
consisted of the guidance modality, biopsy method (core 
biopsy versus FNA), use of a coaxial needle, biopsy needle 
size (22 G, 20 G/19 G, or 18 G/17 G), number of tissue 
samples, and number of pleural passages. If a coaxial 
needle was used, the size of the outer coaxial needle was 
recorded. 
Complications, including pneumothorax, pneumothorax 
requiring chest tube insertion, hemoptysis, and other rare 
complications, were assessed by reviewing the medical 
records that were created during the procedure and up 
to a week after. In fluoroscopy- or US-guided PTNBs, the 
presence of PTNB-related pneumothorax was assessed on 
the basis of chest radiographs, which were typically taken 3 
hours after the PTNB. Intraprocedural and post-procedural 
CT images were used to determine the presence of PTNB-
related pneumothorax in CT-guided, CT fluoroscopy-guided, 
or cone-beam CT-guided PTNBs.
statistical Analysis
The guidance modalities and usage of a coaxial needle 
were extremely biased according to the participating 
hospital (Table 1). Accordingly, hospital-associated effects 
were not appropriately separated from the effects of the 
guidance modalities and usage of a coaxial needle. As all 
Table 1. Guidance Modalities and Usage of Coaxial Needle for Percutaneous Transthoracic Needle Biopsy According to Participating 
Institutions 
Participating Institutions
A B C D E F G H
Guidance modalities (%)
Fluoroscopy 0 100 5 3 93 0 0 19
CT 0 0 86 97 6 0 100 0
CT fluoroscopy 0 0 0 0 0 0 0 76
Cone-beam CT 97 0 0 0 0 100 0 0
Ultrasonography 3 0 9 0 1 0 0 5
Usage of coaxial needle (%)
Coaxial needle 0 100 0 94 100 3 2 99
Non-coaxial needle 100 0 100 6 0 97 98 1
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participating hospitals were major regional referral hospitals 
and the affiliated thoracic radiologists had similar levels 
of experience performing PTNBs, we acknowledged the 
limitations of our data and cautiously decided to analyze 
the impact of the guidance modalities on the complication 
rates of PTNB, while excluding a hospital effect. Univariate 
and multivariate logistic regression analyses were performed 
to identify risk factors for pneumothorax, pneumothorax 
requiring chest tube insertion, and hemoptysis. In the 
multivariate logistic regression analysis, all variables with 
a p value of 0.10 or less were entered into the final model. 
Biopsy method was also included in the multivariate model 
though it had a p value > 0.1 in the univariate analysis, 
since the biopsy method was a main factor affecting the 
PTNB complication rate (6). P values of 0.05 or smaller were 
considered to indicate statistical significance. Statistical 
analysis was performed using SPSS version 22.0 (IBM Corp., 
Armonk, NY, USA).
ResUlTs
Patient and lesion characteristics are summarized in Table 
2. Of the 10568 biopsies, pneumothorax occurred in 21.7% 
(95% CI, 20.9–22.5%; 2298 biopsies), with tube insertion 
subsequently required in 3.0% (95% CI, 2.7–3.3%; 316 
biopsies), while hemoptysis occurred in 5.2% (95% CI, 
4.8–5.6%; 550 biopsies). Other rare complications included 
hemothorax in 0.57% of the biopsies (95% CI, 0.43–0.73%; 
59 biopsies), vasovagal syncope in 0.07% (95% CI, 
0.03–0.15%; 7 biopsies), intra-abdominal injury in 0.03% 
(95% CI, 0.01–0.09%; 3 biopsies), air embolism in 0.02% 
(95% CI, 0.00–0.08%; 2 biopsies), and death in 0.01% 
(95% CI, 0.00–0.06%; 1 biopsy). Among the 59 biopsies 
with hemothorax, 71.9% and 93.0% were performed in the 
prone position and with core biopsy, respectively, compared 
to biopsies without hemothorax (60.0% and 54.4%, 
respectively), while other characteristics were similar. 
Pneumothorax
Univariate logistic regression analysis identified the 
following significant risk factors (Supplementary Table 1 in 
the online-only Data Supplement): older age (p = 0.001), 
male sex (p < 0.001), smoking history (p < 0.001), guidance 
modality (p < 0.001–0.003), lobar location (p < 0.001–
0.854), lesion diameter (p < 0.001), lesion composition (p 
= 0.002), emphysema (p < 0.001), a deep-seated lesion (p 
< 0.001), biopsy method (p < 0.001), needle gauge (p < Ta
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0.001), and number of pleural passages (p < 0.001–0.608).
In the multivariate logistic regression analysis including 
these factors (Table 3), pneumothorax was positively 
associated with all 3 CT-based guidance modalities. CT (odds 
ratio [OR], 2.752 [95% CI, 2.325–3.258]; p < 0.001), CT 
fluoroscopy (OR, 1.440 [95% CI, 1.176–1.762]; p < 0.001), 
and cone-beam CT (OR, 2.906; [95% CI, 2.235–3.779]; 
p < 0.001) were significant independent risk factors for 
pneumothorax, while ultrasonography was a significant 
independent protector for pneumothorax (OR, 0.170; [95% 
CI, 0.053–0.547]; p = 0.003). 
Other independent risk factors included older age (OR, 
1.284; [95% CI, 1.145–1.440]; p < 0.001), male sex (OR, 
1.178; [95% CI, 1.017–1.366]; p = 0.029), a lesion in the 
right middle lobe (OR, 1.446; [95% CI, 1.192–1.754]; p 
< 0.001), a lesion smaller than 2 cm (OR, 1.604 [95% CI, 
1.442–1.784]; p < 0.001), subsolid composition (OR, 1.411 
[95% CI, 1.151–1.730]; p = 0.001), emphysema (OR, 1.548 
[95% CI, 1.372–1.747]; p < 0.001), a deep-seated lesion 
located between 2 and 4 cm from the pleura (OR, 1.805 [95% 
CI, 1.617–2.015]; p < 0.001) or deeper than 4 cm (OR, 2.518 
[95% CI, 2.189–2.896]; p < 0.001), 2 pleural passages (OR, 
1.784 [95% CI, 1.498–2.126]; p < 0.001), and three or 
more pleural passages (OR, 3.153 [95% CI, 2.502–3.974]; p 
< 0.001). Smoking history was a marginally significant risk 
factor for pneumothorax (OR, 1.155 [95% CI, 1.000–1.333]; 
p = 0.050).
Pneumothorax Requiring Chest Tube Insertion
In the univariate logistic regression analysis for 
pneumothorax requiring chest tube insertion (Supplementary 
Table 2 in the online-only Data Supplement), at least 
marginal statistical significance was found for older age 
(p < 0.001), male sex (p < 0.001), smoking history (p 
< 0.001), guidance modality (p < 0.001–0.996), lobar 
location (p = 0.007–0.504), lesion diameter (p = 0.021), 
lesion composition (p = 0.046), emphysema (p < 0.001), 
a deep-seated lesion (p < 0.001), an immediate position 
change after PTNB (p < 0.001), biopsy method (p < 0.001), 
needle gauge (p = 0.001–0.074), and the number of pleural 
passages (p = 0.001–0.047).
The multivariate logistic regression analysis revealed 
that none of the 3 CT-based guidance modalities, including 
CT (OR, 1.149 [95% CI, 0.769–1.718]; p = 0.497), CT 
fluoroscopy (OR, 0.767 [95% CI, 0.501–1.174]; p = 0.222), 
and cone-beam CT (OR, 1.482 [95% CI, 0.765–2.764]; 
p = 0.216) increased the risk of pneumothorax requiring 
chest tube insertion (Table 4). Older age (OR, 1.521 [95% 
CI, 1.125–2.057]; p = 0.006), a lesion smaller than 2 cm 
(OR, 1.383 [95% CI, 1.075–1.780]; p = 0.012), subsolid 
composition (OR, 1.557 [95% CI, 1.005–2.413]; p = 0.048), 
emphysema (OR, 2.745 [95% CI, 2.104–3.581]; p < 0.001), 
a deep-seated lesion located between 2 and 4 cm from 
the pleura (OR, 2.779 [95% CI, 2.117–3.647]; p < 0.001) 
or deeper than 4 cm (OR, 4.318 [95% CI, 3.167–5.886]; p 
< 0.001), and three or more pleural passages (OR, 2.024 
[95% CI, 1.282–3.195]; p = 0.002) were other significant 
independent risk factors. A rapid needle-out patient-rollover 
approach was the sole significant independent protector (OR, 
0.600 [95% CI, 0.439–0.820]; p = 0.001)
hemoptysis
In the univariate analysis, female sex (p < 0.001), 
smoking history (p < 0.001), guidance modality (p < 0.001–
Table 3. Multivariate logistic Regression Analysis of Risk 
Factors for Pneumothorax
P OR (95% CI)
Age ≥ 60 years (vs. < 60 years) < 0.001* 1.284 (1.145–1.440)
Male (vs. female) 0.029* 1.178 (1.017–1.366)
Smoking (vs. non-smoker) 0.050 1.155 (1.000–1.333)
Guiding modality (vs. fluoroscopy)
CT < 0.001* 2.752 (2.325–3.258)
CT fluoroscopy < 0.001* 1.440 (1.176–1.762)
Cone-beam CT < 0.001* 2.906 (2.235–3.779)
Ultrasonography 0.003* 0.170 (0.053–0.547)
Lobe (vs. right upper lobe)
Right middle lobe < 0.001* 1.446 (1.192–1.754)
Right lower lobe 0.561 1.041 (0.908–1.194)
Left upper lobe 0.992 1.001 (0.875–1.145)
Left lower lobe 0.917 1.008 (0.867–1.172)
Nodule of 2 cm or less  
  (vs. > 2 cm)
< 0.001* 1.604 (1.442–1.784)
Subsolid composition (vs. solid) 0.001* 1.411 (1.151–1.730)
Emphysema < 0.001* 1.548 (1.372–1.747)
Distance from pleura (vs. ≤ 2 cm)
2–4 cm < 0.001* 1.805 (1.617–2.015)
> 4 cm < 0.001* 2.518 (2.189–2.896)
Core biopsy (vs. FNA) 0.660 1.072 (0.786–1.463)
Needle gauze (vs. 22 G)
19–20 G 0.648 1.085 (0.763–1.544)
17–18 G 0.549 0.895 (0.623–1.286)
Number of pleural passage (vs. 1)
2 < 0.001* 1.784 (1.498–2.126)
≥ 3 < 0.001* 3.153 (2.502–3.974)
*Statistical significance below 0.05. CI = confidence interval, FNA = 
fine-needle aspiration, OR = odds ratio
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0.061), lesion diameter (p = 0.001), lesion composition (p 
< 0.001), emphysema (p < 0.001), a deep-seated lesion (p 
< 0.001), needle gauge (p = 0.003–0.182), and the number 
of pleural passages (p = 0.011–0.499) showed statistical 
significance (Supplementary Table 3 in the online-only 
Data Supplement). The multivariate analysis included those 
variables, and we added the biopsy method (p = 0.295) to 
the final model. 
In comparison with fluoroscopy, all 3 CT-based guidance 
modalities, namely, CT (OR, 0.348 [95% CI, 0.247–0.491]; p 
< 0.001), CT fluoroscopy (OR, 0.594 [95% CI, 0.419–0.843]; 
p = 0.004), and cone-beam CT (OR, 0.479; [95% CI, 0.317–
0.724]; p < 0.001) were significant independent protectors 
against hemoptysis (Table 5). In addition, female sex (OR, 
1.495 [95% CI, 1.154–1.937]; p = 0.002), a lesion smaller 
than 2 cm (OR, 1.226 [95% CI, 1.012–1.486]; p = 0.037), 
subsolid composition (OR, 1.685 [95% CI, 1.232–2.304]; p 
= 0.001), and a deep-seated lesion located between 2 and 
4 cm from the pleura (OR, 1.573 [95% CI, 1.288–1.922]; p 
< 0.001) or deeper than 4 cm (OR, 2.531 [95% CI, 2.003–
3.199]; p < 0.001), and core biopsy (OR, 1.595 [95% CI, 
1.001–2.541]; p = 0.049) were significant risk factors for 
hemoptysis, while emphysema (OR, 0.740 [95% CI, 0.570–
0.961]; p = 0.024) was a significant protective factor. 
DIsCUssION
This large retrospective cohort study revealed that 
hemoptysis occurred less frequently when using CT-
based guidance modalities. Although pneumothorax 
requiring chest tube insertion showed a similar incidence, 
pneumothorax was more frequently detected using CT-based 
guidance modalities. 
In comparison with fluoroscopy, CT (OR, 0.348 [95% 
CI, 0.247–0.491]; p < 0.001), CT fluoroscopy (OR, 0.594 
[95% CI, 0.419–0.843]; p = 0.004), and cone-beam CT (OR, 
0.479; [95% CI, 0.317–0.724]; p < 0.001) were significant 
independent protectors against hemoptysis. CT and CT-
based guidance modalities are more advantageous than 
fluoroscopy for preprocedural planning and intraprocedural 
tracking of needle placement. Furthermore, penetration 
Table 4. Multivariate logistic Regression Analysis of Risk 
Factors for Pneumothorax Requiring Chest Tube Insertion
P OR (95% CI)
Age ≥ 60 (vs. < 60) 0.006* 1.521 (1.125–2.057)
Male (vs. female) 0.693 1.081 (0.734–1.592)
Smoking (vs. non-smoker) 0.137 1.326 (0.914–1.923)
Guiding modality (vs. fluoroscopy)
CT 0.497 1.149 (0.769–1.718)
CT fluoroscopy 0.222 0.767 (0.501–1.174)
Cone-beam CT 0.216 1.482 (0.765–2.764)
Ultrasonography 0.996 Not available
Lobe (vs. right upper lobe)
Right middle lobe 0.499 0.849 (0.528–1.365)
Right lower lobe 0.402 0.870 (0.629–1.204)
Left upper lobe 0.114 0.783 (0.578–1.060)
Left lower lobe 0.334 0.833 (0.575–1.207)
Nodule of 2 cm or less (vs. > 2 cm) 0.012* 1.383 (1.075–1.780)
Subsolid composition (vs. solid) 0.048* 1.557 (1.005–2.413)
Emphysema < 0.001* 2.745 (2.104–3.581)
Distance from pleura (vs. ≤ 2 cm)
2–4 cm < 0.001* 2.779 (2.117–3.647)
> 4 cm < 0.001* 4.318 (3.167–5.886)
Rapid needle-out patient-rollover 
  approach
0.001* 0.600 (0.439–0.820)
Core biopsy (vs. FNA) 0.186 0.612 (0.295–1.268)
Needle gauze (vs. 22 G)
19–20 G 0.640 1.230 (0.517–2.925)
17–18 G 0.934 0.965 (0.411–2.264)
Number of pleural passage (vs. 1)
2 0.178 1.286 (0.892–1.853)
≥ 3 0.002* 2.024 (1.282–3.195)
*Statistical significance below 0.05. 
Table 5. Multivariate logistic Regression Analysis of Risk 
Factors for hemoptysis
P OR (95% CI)
Female (vs. male) 0.002* 1.495 (1.154–1.937)
Smoking (vs. non-smoker) 0.058 0.773 (0.593–1.008)
Guiding modality (vs. fluoroscopy)
CT < 0.001* 0.348 (0.247–0.491)
CT fluoroscopy 0.004 0.594 (0.419–0.843)
Cone-beam CT < 0.001* 0.479 (0.317–0.724)
Ultrasonography 0.093 0.294 (0.070–1.228)
Nodule of 2 cm or less (vs. > 2 cm) 0.037* 1.226 (1.012–1.486)
Subsolid composition (vs. solid) 0.001* 1.685 (1.232–2.304)
Emphysema 0.024* 0.740 (0.570–0.961)
Distance from pleura (vs. ≤ 2 cm)
2–4 cm < 0.001* 1.573 (1.288–1.922)
> 4 cm < 0.001* 2.531 (2.003–3.199)
Core biopsy (vs. FNA) 0.049* 1.595 (1.001–2.541)
Needle gauze (vs. 22 G)
19–20 G 0.164 0.653 (0.359–1.189)
17–18 G 0.945 0.981 (0.565–1.701)
Number of pleural passage (vs. 1)
2 0.490 1.107 (0.829–1.479)
≥ 3 0.219 0.760 (0.491–1.177)
*Statistical significance below 0.05. 
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and cutting injuries of the large vessels and bronchi can 
be avoided by reviewing the location of the needle tip 
before aspiration or firing the biopsy gun (4). This precise 
anatomic evaluation could potentially reduce the incidence 
of hemoptysis. In line with the results of a prior publication 
(10), needle gauge and the number of pleural penetrations 
were not associated with hemoptysis. 
In the multivariate analysis, female sex, lesions smaller 
than 2 cm, subsolid composition, deep-seated lesions, 
and core biopsy also showed statistical significance, and 
these are well-recognized risk factors for hemoptysis, as 
hemoptysis is associated with the less compact nature of 
small subsolid lesions compared to large solid lesions and 
the higher chances of tissue injuries in core biopsy than in 
FNA (10-13). The higher prevalence of subsolid lesions in 
female patients might be partly responsible for the higher 
incidence of hemoptysis in female patients, although 
both lesion composition and sex were adjusted in the 
multivariate analysis. Interestingly, emphysema was found 
to be a significant protector against hemoptysis. Smoking 
induces pulmonary vascular remodeling, and in patients 
with severe emphysema, pulmonary capillaries decrease 
due to apoptosis of the pulmonary epithelium (14). These 
pathophysiologic changes may be associated with the lower 
incidence of hemoptysis after PTNB. A larger prospective 
study will help clarify the association of emphysema with 
hemoptysis. 
The higher incidence of pneumothorax in PTNBs 
performed using CT-based guidance modalities than in 
PTNBs performed using fluoroscopy is presumed to be a 
detection issue rather than a true increase in the occurrence 
of pneumothorax. In the CT-based guidance modalities, 
the presence of pneumothorax was usually evaluated 
on CT images that were taken during the procedure and 
immediately after the completion of PTNB; thus, even 
a minute amount of pneumothorax could be found. In 
contrast, post-procedural chest radiography was used for 
assessing the presence of pneumothorax in fluoroscopy-
guided PTNB. On chest radiographs, even a considerable 
amount of pneumothorax can be missed (15). The finding 
showing similar incidence rates of pneumothorax requiring 
tube insertion across guidance modalities supports the 
proposal that the more sensitive detection of pneumothorax 
resulted in the higher overall incidence of pneumothorax in 
the CT-based guidance modalities.
The independent risk factors for pneumothorax included 
older age, male sex, a history of smoking, a lesion in 
the right middle lobe, a lesion smaller than 2 cm, a 
subsolid lesion, emphysema, a deep-seated lesion, and 
multiple pleural passages. Indeed, relevant studies have 
indicated that smaller lesions and deeper parenchymal and 
greater number of pleural penetrations during the PTNB 
result in more frequent pneumothorax, and most of the 
aforementioned risk factors are in agreement with prior 
studies (11, 16-18), except for a lesion in the right middle 
lobe and subsolid composition of the lesion. The higher 
incidence of pneumothorax in older patients and male 
patients potentially results from the reduced lung elasticity 
with aging (19) and the higher recoil pressure in male 
patients (20). As the right middle lobe is surrounded by 
major and minor fissures, a transfissural approach may be 
more frequently required for a right middle lobar lesion than 
for other lobar lesions (17). We were not able to determine 
whether a PTNB was performed via a transfissural route, 
and the higher incidence of pneumothorax in right middle 
lobar lesions may be associated with the more frequent 
use of transfissural approaches. A higher incidence of 
pneumothorax in subsolid lesions may be explainable by the 
weaker compression of internal bronchial structures by loose 
pathologic tissue after the biopsy injury than is the case 
for solid lesions (21). Further investigation is warranted 
to confirm the association between pneumothorax and 
subsolid lesions.
The sole independent protector against pneumothorax 
requiring chest tube insertion was a rapid needle-out 
patient-rollover approach. The patient biopsy-side-down 
position potentially reduces the incidence of pneumothorax 
by decreasing the size of the alveoli surrounding the needle 
track, subsequently causing airway closure and elevated 
resistance to collateral ventilation in the dependent 
lung (22, 23). We validated the observations recorded 
by O’Neill et al. (22) in a large population. Nevertheless, 
some discrepancies exist between their results and ours: 
this approach reduced the overall pneumothorax rate in 
the study of O’Neill et al. (22), but not in ours. Vigorous 
turnover was not uniformly applicable to all patients in 
our clinical practice, and uncontrolled respiration by the 
patient during a position change may cause a small amount 
of air leakage through the puncture site or needle tract, as 
observed by Kim et al. (23). The independent risk factors 
for pneumothorax requiring chest tube insertion were a 
lesion smaller than 2 cm, a subsolid lesion, emphysema, a 
deep-seated lesion, and multiple pleural passages (three 
times or higher); these risk factors are consistent with prior 
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observations (4, 17, 18). 
Interestingly, a lesion in the right middle lobe and 
twice-pleural passages were risk factors for pneumothorax 
but not for pneumothorax requiring chest tube insertion. 
These discrepancies may be partly explained by the 
amount of pneumothorax after biopsy: the large amount of 
pneumothorax requiring tube drainage is less likely to occur 
with twice-pleural passages or a potential transfissural 
approach. In addition, neither needle gauze nor core 
biopsy were risk factors for pneumothorax or pneumothorax 
requiring chest tube insertion. This observation indicates 
that the size of the pleural injury when the needle 
penetrates a pleura did not affect the overall occurrence of 
pneumothorax but potentially resulted in non-immediate 
pneumothorax (18). 
Hemothorax is one of the rare complications after 
PTNB. It occurred in 0.57% of the biopsies, which was 
consistent with prior observations (0.20–0.92%) (11, 24, 
25). There were two potential risk factors for hemothorax: 
prone position and core biopsy. The association between 
hemothorax and prone position may result from the varying 
vertical position of intercostal vessels within the intercostal 
space around the spine where the intercostal vessel is 
not shielded by the intercostal groove of the superior rib 
(26). Similarly, in core biopsy, intercostal vessels may be 
exposed to the active part of the biopsy needle and may 
be subsequently injured when PTNB is performed for a 
subpleural lesion (27). Another rare complication after 
PTNB is air embolism. The incidence of air embolism in 
our population was 0.02%, which was consistent with 
the reported incidence (range, 0.02–0.07%) in relevant 
publications (25, 28, 29). 
This study has several limitations, as our cohort was 
collected in a retrospective manner. The impact of guiding 
modalities on complication rates in PTNB was evaluated 
without considering a hospital effect. As mentioned earlier, 
the choice of guidance modality and usage of a coaxial 
needle showed an extremely uneven distribution among 
the participating institutions. Thoracic radiologists have 
their own preferences for a particular guidance modality 
and for the usage of a coaxial or non-coaxial needle; such 
variations could not be resolved in an observational cohort 
study, and we were not able to appropriately evaluate the 
hospital effect on complications of PTNB. Nevertheless, 
given the similar referral settings and experience levels of 
the affiliated thoracic radiologists across the participating 
hospitals, we believe that our approach could evaluate the 
impact of CT-based imaging modalities for needle guidance 
on complications in the study population. The use of a 
transfissural approach for PTNB was not analyzed in our 
population. This confounder may have affected the results 
of our risk factor analysis for pneumothorax. In addition, 
although we regarded repeat biopsies for the same lesion 
as separate initial PTNBs, pulmonary lesions demanding a 
repeated biopsy may have specific characteristics affecting 
the complication rate.
In conclusion, when compared with fluoroscopy, 
hemoptysis occurred less frequently using CT-based 
guidance modalities; while pneumothorax requiring chest 
tube insertion showed a similar incidence, pneumothorax 
was more frequently detected. A rapid needle-out patient-
rollover approach was effective for reducing the need for 
chest tube insertion due to pneumothorax. Understanding 
the benefits and limitations of CT-based guidance modalities 
in terms of complications will be helpful for selecting the 
appropriate guidance modality for PTNB.
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